BISPHOSPHONATES IN PROPHYLAXIS OF SKELETAL-RELATED ADVERSE EVENTS IN PATIENTS WITH CASTRATION-REFRACTORY PROSTATE CANCER
Prostate cancer (PC) is one of the most urgent problems of modern oncourology. Morbidity and mortality from this disease in theRussian Federationin recent years has been steadily increasing. Including the number of patients with metastatic and refractory to castration therapy forms of the disease is...
Saved in:
Main Authors: | E. Yu. Safronova, S. A. Sergienko, A. S. Kalpinskiy, N. V. Vorobyev, A. A. Kostin, A. D. Kaprin |
---|---|
Format: | Article |
Language: | Russian |
Published: |
QUASAR, LLC
2016-06-01
|
Series: | Исследования и практика в медицине |
Subjects: | |
Online Access: | https://www.rpmj.ru/rpmj/article/view/142 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PREVENTION OF COMPLICATIONS IN CASTRATE-REFRACTORY PROSTATE CANCER PATIENTS WITH BONE METASTASES
by: K. M. Nushko, et al.
Published: (2015-10-01) -
Zoledronic acid in the treatment of osteoporosis: indications for use
by: Nataliya Vladimirovna Toroptsova, et al.
Published: (2011-06-01) -
Treatment of bone complications in multiple myeloma patients
by: V. V. Ptushkin
Published: (2022-11-01) -
The use of bisphosphonates for the treatment and prevention of osteoporosis
by: O. A. Nikitinskaya, et al.
Published: (2022-08-01) -
RADIUM-223. PLACE IN THE TREATMENT OF METASTATIC CASTRATION-REFRACTORY PROSTATE CANCER
by: A. A. Kostin, et al.
Published: (2017-12-01)